STEPHANIE ACKNER: Open Payments
NPI 1285734566 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,010 in 50 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,010
Food & beverage: $898Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 12 | $286 |
| E.R. Squibb & Sons, L.L.C. | 14 | $185 |
| Vanda Pharmaceuticals Inc. | 5 | $143 |
| Otsuka America Pharmaceutical, Inc. | 7 | $138 |
| Neurocrine BioSciences, Inc. | 4 | $100 |
| Lundbeck LLC | 3 | $59 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
| Alkermes, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
Products named: COBENFY, UZEDY, ABILIFY MAINTENA, INGREZZA, HETLIOZ, REXULTI, FANAPT, AUSTEDO XR.
Industry payments across OH — which companies pay providers there.
